Accelmed is a provider of venture capital that finances private and public medical device enterprises that have a demonstrated clinical track record and market viability.
26
Total Investments
17
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Health Care
Funding Stage
Seed +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Accelmed Partners
Recent Investments (26)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | May 2023 | |
| Post-IPO Equity | •••••• | Dec 2022 | |
| Debt Financing | •••••• | Aug 2022 | |
| Venture Round | •••••• | Aug 2022 | |
| Series B | •••••• | Jul 2022 | |
|
|
Private Equity Round | •••••• | May 2022 |
|
|
Series B | •••••• | Oct 2021 |
|
|
Late Vc | •••••• | Sep 2021 |
|
|
Venture Round | •••••• | Jun 2021 |
|
|
Series B | •••••• | May 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.